Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening
| Status: | Completed |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | December 2011 |
| End Date: | December 2012 |
| Contact: | Christopher Warlick, M.D. |
| Email: | cwarlick@umn.edu |
| Phone: | 612-625-7486 |
Decision-aids are tools to educate patients on a given topic so that they may better
participate in shared-decision making in their health care. Given the complexities
associated with PSA testing, many professional organizations have advocated for
shared-decision making for PSA testing. However, no consensus exists as to how best educate
and involve patients in the shared-decision making process. The goal of this study is to
evaluate a pilot program utilizing a simple PSA screening decision-aid presented in two
different fashions in a primary care clinic with a large fraction of African-American
patients. The investigators will evaluate the effectiveness of this program to educate
patients on the risks and benefits of prostate specific antigen (PSA) testing, on their
subsequent level of comfort with their decision about whether to receive PSA testing, and on
the comfort level of physicians on their patient's decisions regarding PSA testing, and
importantly, how well these strategies can be implemented into the daily work-flow of a
clinic. If successful, this program may serve as a model for the broader implementation of
such strategies across Minnesota and the country.
This pilot project will evaluate two approaches to implementing the use of a simple printed
PSA screening decision-aid (DA) administered in an urban primary care clinic populated with
a significant number of African-Americans. All subjects will complete a survey assessing
their knowledge and attitudes about PSA screening and shared decision making (SDM), and
physicians will also be briefly queried about their perceptions of the SDM process.
After the first three month implementation period we will conduct focus groups with clinic
staff to guide changes and refinements to the use of DA in the clinical setting. Another
three month implementation period will follow using the same methods to assess outcomes.
Finally we will conduct another round of focus groups to assess the overall impact of the
interventions.
Inclusion criteria:
- Males ages 50-75
- Able to read and speak English
- Provide written informed consent
Exclusion criteria:
- Diagnosis of prostate cancer
- PSA testing within last 12 months
- Previous prostate biopsy
- Voiding problems as reason for clinic visit
- Visit scheduled same day or 'walk-In' patient
We found this trial at
1
site
Click here to add this to my saved trials
